These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3118272)

  • 41. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Animal-experiment studies on the effect of magnesium and vitamin B 6 on calcium-oxalate nephrolithiasis].
    Schneider HJ; Hesse A; Berg W; Kirsten J; Nickel H
    Z Urol Nephrol; 1977 Jun; 70(6):419-27. PubMed ID: 906678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.
    Thamilselvan S; Hackett RL; Khan SR
    J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Kidney ultrastructure in experimental lithiasis and nephrocalcinosis].
    Blagodarov VN
    Biull Eksp Biol Med; 1976; 81(4):494-6. PubMed ID: 1084176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effects of the oxalate precursors on the experimental calcium oxalate urolithiasis].
    Morozumi M; Ogawa Y; Tanaka T; Yamaguchi K; Kitagawa R
    Nihon Hinyokika Gakkai Zasshi; 1987 Jun; 78(6):1025-31. PubMed ID: 3682493
    [No Abstract]   [Full Text] [Related]  

  • 47. Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis.
    Urivetzky M; Kessaris D; Smith AD
    J Urol; 1992 May; 147(5):1215-8. PubMed ID: 1569652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary hyperoxaluria (glycolic acid variant): a clinical and genetical investigation of eight cases.
    Holmgren G; Hörnström T; Johansson S; Samuelson G
    Ups J Med Sci; 1978; 83(1):65-70. PubMed ID: 705974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [13 cases of drug-induced calculi].
    Teillac P; Daudon M; de Dreuzy O; Nguyen HV; Reveillaud RJ; Le Duc A
    Ann Urol (Paris); 1988; 22(4):278-81. PubMed ID: 2903714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Protective effect of pyridoxilate on the hypoxic myocardium. Experimental studies].
    Moret PR; Lutzen U
    Schweiz Med Wochenschr; 1977 Nov; 107(44):1585-6. PubMed ID: 918622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potentiation by piridoxilate of the synthesis of hippurate from benzoate in isolated rat hepatocytes. An approach to the determination of new pathways of nitrogen excretion in inborn errors of urea synthesis.
    Coude FX; Coude M; Grimber G; Pelet A; Charpentier C
    Clin Chim Acta; 1984 Jan; 136(2-3):211-7. PubMed ID: 6692575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Inhibition of calcium oxalate urolithiasis with pyridoxine and magnesium in an experiment].
    Krídl J; Zvara V; Revúsová V; Gratzlová J; Ondrus B
    Bratisl Lek Listy; 1984 Jan; 81(1):21-8. PubMed ID: 6692164
    [No Abstract]   [Full Text] [Related]  

  • 53. Recurrent calcium oxalate nephrolithiasis induced by naftidrofuryl oxalate.
    Retornaz F; Jean-Pastor MJ; Monestier S; Durand JM; Soubeyrand J
    Nephron; 2000 May; 85(1):92. PubMed ID: 10773762
    [No Abstract]   [Full Text] [Related]  

  • 54. Induced precipitation of calcium-oxalate crystals and its prevention in laboratory animals.
    Götz F; Gimes L; Hübler J; Temes G; Frang D
    Int Urol Nephrol; 1986; 18(4):363-8. PubMed ID: 3102396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insights into the pathophysiology and treatment of patients with calcium oxalate nephrolithiasis.
    Assimos DG
    J Urol; 1998 May; 159(5):1457-8. PubMed ID: 9554332
    [No Abstract]   [Full Text] [Related]  

  • 56. Studies on the effects of piridoxilate, a glyoxylic acid derivative, on the mammalian system, heart and muscle under normal or deficient oxygen supply. Attempts towards a biochemical approach.
    Fourneau JP; Davy M; Clément M; Ransom M; Darmois F; Lamarche M
    Arzneimittelforschung; 1974 Jan; 24(1):27-34. PubMed ID: 4406105
    [No Abstract]   [Full Text] [Related]  

  • 57. [Iatrogenic kidney-calculi formation and kidney failure due to long-term treatment with calcinosis factors (dihydrotachysterol, vitamin D)].
    Gebhardt K
    Z Arztl Fortbild (Jena); 1977 May; 71(9):447-9. PubMed ID: 878519
    [No Abstract]   [Full Text] [Related]  

  • 58. Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide.
    Alon US; Scagliotti D; Garola RE
    J Pediatr; 1994 Jul; 125(1):149-51. PubMed ID: 8021767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measurement of nephrolithiasis urinary markers by capillary electrophoresis.
    García A; Muros M; Barbas C
    J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):287-95. PubMed ID: 11393716
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Spectrum: Nephrocalcinosis-Nephrolithiasis.
    Hsi RS; Stoller ML
    J Urol; 2015 Nov; 194(5):1188-9. PubMed ID: 26279238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.